Jacobs Levy Equity Management, Inc Ironwood Pharmaceuticals Inc Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,475,046 shares of IRWD stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,475,046
Previous 1,580,320
6.66%
Holding current value
$2.33 Million
Previous $2.32 Million
54.28%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding IRWD
# of Institutions
177Shares Held
160MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$36.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$25.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$25.5 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$25.2 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$13.3 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $242M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...